Abhimanyu Verma

CIK: 0002114540

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (90.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (10.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SOPH

SOPHiA GENETICS SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SOPH
SOPHiA GENETICS SA
Oct 5, 2026
Sale(S)
Direct
5.3K shares at avg. $8.12$43K
SOPH
SOPHiA GENETICS SA
Aug 24, 2026
Sale(S)
Direct
5K shares at avg. $8.80$44K
SOPH
SOPHiA GENETICS SA
Aug 19, 2026
Sale(S)
Direct
5K shares at avg. $8.20$41K
SOPH
SOPHiA GENETICS SA
Aug 7, 2026
Sale(S)
Direct
5K shares at avg. $7.60$38K
SOPH
SOPHiA GENETICS SA
Aug 4, 2026
Sale(S)
Direct
5K shares at avg. $6.95$35K
SOPH
SOPHiA GENETICS SA
Jul 6, 2026
Sale(S)
Direct
5.3K shares at avg. $5.10$27K
SOPH
SOPHiA GENETICS SA
Jun 25, 2026
Sale(S)
Direct
6.9K shares at avg. $5.51$38K
SOPH
SOPHiA GENETICS SA
Apr 7, 2026
Sale(S)
Direct
1K shares at avg. $4.87$5K
SOPH
SOPHiA GENETICS SA
Apr 6, 2026
Sale(S)
Direct
2.5K shares at avg. $4.86$12K
SOPH
SOPHiA GENETICS SA
Apr 2, 2026
Award(A)
Direct
82.1K shares-

		Type	Shares	Price		Ownership
Oct 5, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	5,284	$8.12	$42,929	Direct
Aug 24, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	5,000	$8.80	$44,000	Direct
Aug 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	5,000	$8.20	$41,000	Direct
Aug 7, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	5,000	$7.60	$38,000	Direct
Aug 4, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	5,000	$6.95	$34,772	Direct
Jul 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	5,285	$5.10	$26,957	Direct
Jun 25, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	6,944	$5.51	$38,229	Direct
Apr 7, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,030	$4.87	$5,016	Direct
Apr 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,519	$4.86	$12,240	Direct
Apr 2, 2026	SOPH SOPHiA GENETICS SA	Award(A)	82,136	-	$0	Direct

1-10 of 10 transactions

About Verma Abhimanyu

Verma Abhimanyu (SEC CIK 0002114540) files insider reports with the SEC as Chief Technology Officer of SOPHiA GENETICS SA (SOPH).

Signal8 holds 10 ownership filings by Verma Abhimanyu (1 Form 3, 9 Form 4), filed between Mar 18, 2026 and Oct 7, 2026. Those filings report 10 transactions, from Apr 2, 2026 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Verma Abhimanyu's filings is in ROLLE.

Recent filings by Verma Abhimanyu

Oct 5, 2026: Open-market sale of SOPH shares (Form 4, code S).
Aug 24, 2026: Open-market sale of SOPH shares (Form 4, code S).
Aug 19, 2026: Open-market sale of SOPH shares (Form 4, code S).
Aug 7, 2026: Open-market sale of SOPH shares (Form 4, code S).
Aug 4, 2026: Open-market sale of SOPH shares (Form 4, code S).

Other insiders filing for SOPHiA GENETICS SA (SOPH)

Menu Philippe, Chief Medical Officer
Xu Zhenyu, Chief Scientific Officer
Camblong Jurgi, Executive Chairman
Van Well Daan, Chief Legal Officer
Valente Manuela, Chief People Officer
Puylaert Kevin, Chief Sales Officer

How to read Form 4 transaction codes